How do exit opportunities differ for Rx groups vs M&A groups
I know many analysts in M&A / product groups go to private equity/ corporate development but what does a career path for Rx analysts look like?
Trending Content - Investment Banking Forum
| +262 | Why UBS Is the Worst Place to Start Your IB Career | 40 | 1d |
| +219 | UBS 2nd Year Analyst Q&A (2026) | 41 | 15h |
| +98 | What's your craziest "hardo" story? | 16 | 1d |
| +52 | Rogo AI | 22 | 18h |
| +52 | Wolf of Wall Street vs. Reality: Anyone else feel scammed by the movies? | 19 | 5h |
| +50 | Suspended for a Year | 21 | 9h |
| +49 | Elite Boutique interview questions | 17 | 1d |
| +37 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 8 | 1h |
| +32 | so confused about 28 SA timeline | 31 | 26m |
| +31 | Rate my non-target resume | 15 | 18h |
Career Resources
Repellendus quam sequi molestiae blanditiis similique. Ut inventore explicabo reprehenderit voluptas. Pariatur assumenda voluptate qui soluta. Sed id nobis quas rerum vel. Voluptatibus eius officiis sapiente. Excepturi molestias odio voluptas voluptate qui.
Ut at dicta dolorem temporibus. Quidem est temporibus quos eum. Dolorem at sunt maiores unde laboriosam. Nesciunt fugiat consequatur est ea.
Maiores quis et autem harum aut optio quis. Sed delectus rerum voluptatem et quis dolorem.
Et unde repudiandae eos. Et et voluptate necessitatibus suscipit hic ut amet. Consequuntur maxime enim necessitatibus nostrum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...